Wilfrid Laurier University

Scholars Commons @ Laurier
Theses and Dissertations (Comprehensive)
2008

Effects and Mechanisms of Female Sex Hormone Influence on
Skeletal Muscle Inflammation
Sobia Iqbal
Wilfrid Laurier University

Follow this and additional works at: https://scholars.wlu.ca/etd
Part of the Kinesiology Commons

Recommended Citation
Iqbal, Sobia, "Effects and Mechanisms of Female Sex Hormone Influence on Skeletal Muscle
Inflammation" (2008). Theses and Dissertations (Comprehensive). 867.
https://scholars.wlu.ca/etd/867

This Thesis is brought to you for free and open access by Scholars Commons @ Laurier. It has been accepted for
inclusion in Theses and Dissertations (Comprehensive) by an authorized administrator of Scholars Commons @
Laurier. For more information, please contact scholarscommons@wlu.ca.

1*1

Library and
Archives Canada

Bibliotheque et
Archives Canada

Published Heritage
Branch

Direction du
Patrimoine de I'edition

395 Wellington Street
Ottawa ON K1A0N4
Canada

395, rue Wellington
Ottawa ON K1A0N4
Canada

Your file Votre reference
ISBN: 978-0-494-38715-3
Our file Notre reference
ISBN: 978-0-494-38715-3

NOTICE:
The author has granted a nonexclusive license allowing Library
and Archives Canada to reproduce,
publish, archive, preserve, conserve,
communicate to the public by
telecommunication or on the Internet,
loan, distribute and sell theses
worldwide, for commercial or noncommercial purposes, in microform,
paper, electronic and/or any other
formats.

AVIS:
L'auteur a accorde une licence non exclusive
permettant a la Bibliotheque et Archives
Canada de reproduire, publier, archiver,
sauvegarder, conserver, transmettre au public
par telecommunication ou par Plntemet, prefer,
distribuer et vendre des theses partout dans
le monde, a des fins commerciales ou autres,
sur support microforme, papier, electronique
et/ou autres formats.

The author retains copyright
ownership and moral rights in
this thesis. Neither the thesis
nor substantial extracts from it
may be printed or otherwise
reproduced without the author's
permission.

L'auteur conserve la propriete du droit d'auteur
et des droits moraux qui protege cette these.
Ni la these ni des extraits substantiels de
celle-ci ne doivent etre imprimes ou autrement
reproduits sans son autorisation.

In compliance with the Canadian
Privacy Act some supporting
forms may have been removed
from this thesis.

Conformement a la loi canadienne
sur la protection de la vie privee,
quelques formulaires secondaires
ont ete enleves de cette these.

While these forms may be included
in the document page count,
their removal does not represent
any loss of content from the
thesis.

Bien que ces formulaires
aient inclus dans la pagination,
il n'y aura aucun contenu manquant.

Canada

EFFECTS AND MECHANISMS OF FEMALE SEX HORMONE
INFLUENCE ON SKELETAL MUSCLE INFLAMMATION
by
Sobia Iqbal
Bachelor of Science, Biochemistry, University of Waterloo, 2005

THESIS
Submitted to Kinesiology and Physical Education, Faculty of Science
in partial fulfillment of the requirements for
Master of Science
Wilfrid Laurier University
2008©

Abstract
Previous work from our laboratory has demonstrated that estrogen will attenuate
leukocyte infiltration into skeletal muscle following eccentric exercise. However the
mechanisms by which estrogen exerts its effects are still uncertain. In experiment one, we
investigated the role of estrogen receptor (ER) influence on muscle leukocyte infiltration
following eccentric exercise through administration of the ER antagonist ICI 182,780
following downhill running in ovariectomized female rats with (E+) or without (E-)
estrogen supplementation. At 24 hours post-exercise, soleus and white vastus muscles
were removed and immunostained for HIS48 (neutrophil) and EDI (macrophage)
positive cells. The increase in number of fibres positive for HIS48 in soleus and positive
for EDI in the soleus and white vastus was significantly attenuated (p<0.05) in Enrelative to E- rats at 24 hours post-exercise. E+ rats administered the ER agonist also had
significantly (p<0.05) attenuated 24 h post-exercise increases in HIS48 and EDI positive
soleus and white vastus muscle fibres similar (p>0.05) to those without ER antagonist.
This suggests that the ability of estrogen to attenuate post-exercise leukocyte infiltration
into skeletal muscle is not ER-mediated.
In experiment two, we examined the interaction effects of estrogen and
progesterone on skeletal muscle in response to injury in ovariectomized female rats. At
24 hours post-exercise, soleus and white vastus muscles were removed and
immunostained for HIS48 (neutrophil) and EDI (macrophage) positive cells. Leukocyte
infiltration 24 hours post-exercise in the soleus (red) and white vastus muscles were
significantly decreased in ovariectomized rats treated with progesterone alone relative to
unsupplemented ovariectomized rats. Following exercise the percentage of leukocyte

ii

infiltration also decreased significantly with estrogen supplementation alone in both
muscle types, 67-69% and 63-74% in neutrophils and macrophages, respectfully.
Furthermore, the combination of estrogen and progesterone supplementation did not
significantly alter the attenuation observed by estrogen alone. These results demonstrate
that skeletal muscle in female rats benefited from both progesterone or estrogen treatment
alone; effects of progesterone with estrogen following exercise were neither greater nor
less than with estrogen alone.
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Chapter One

Introduction
Skeletal muscle is a vital component of the body. Skeletal muscle is composed of muscle
fibres that function together to perform contractions. The force generated through these
contractions enables movement in the body. Skeletal muscle function can be impaired by
trauma resulting from crush injury, lacerations, disuse and excessive exercise (1).

1.1 Skeletal Muscle Injury
Unaccustomed strenuous exercise, especially eccentric exercise can, cause muscle
damage. Eccentric muscle contractions allow the muscle to develop force as it is being
lengthened by an external load. McCully and Faulkner (2) investigated exercise-induced
muscle injury proximal to the distal tendon of the extensor digitorum longus (EDL)
muscle of anesthetized mice. The muscle was exposed to bouts of eccentric, concentric
or isometric contractions, for which the muscle length, muscle velocity, level of muscle
activation and the number of contractions were controlled. Following the contraction
protocols the distal tendon was reattached and the animals were allowed to recover.
Three days post-exercise, eccentric contractions in the muscle showed histological signs
of damage and a reduction in maximum isometric muscle force. Exercise protocols of
equivalent intensities involving isometric and concentric contractions did not result in as
much muscle injury as those observed with the eccentric contractions (2). Eccentric
exercise causes more damage than concentric exercise. This is thought to be because
fewer motor units are recruited during eccentric exercise, resulting in a smaller cross-

sectional area that is available to handle the same load that would be handled in a
concentric contraction (3).
Damage to muscle structures has been shown to occur following a bout of
strenuous exercise. Muscle damage can be manifested as a loss in muscle function or
mechanical disruptions in the muscle architecture. The functional implications of muscle
damage include a reduced range of motion in joints, stiffness, altered fatigability, reduced
muscle shortening velocity, and prolonged strength loss in muscles (4).
Eccentric exercises typically result in approximately 10-30% force loss
immediately following exercise (5). High force eccentric exercise (exercise consisting of
maximal eccentric actions) results in muscle strength loss of about 40-60% immediately
after exercise, and strength is not fully recovered until about 10 days later (6; 7). Since
muscle injury has an impact on performance in the workplace, home and on the athletic
field, it is important to understand the mechanism behind muscle damage in order to
devise means to prevent or reduce the detrimental effects.
Immediately following eccentric contractions many sarcomeres show signs of
disruption and damage. Newhan et al. (8) found single disrupted sarcomeres and
disrupted half-sarcomeres, surrounded by normal appearing sarcomeres under the
electron microscope, following eccentric contractions of human quadriceps muscles. In
the disrupted sarcomeres the myofilaments were disorganized and Z-band material was
seen to be "streamed" across the sarcomeres or a widening of the Z-band was apparent
(8). Friden et al. (9) supported the findings of Z-band disorganization following
eccentrically induced muscle damage in human soleus muscles. Following injury, the Zband material, which normally has a regular and discrete structure, was streamed and in

2

some cases there was a complete disruption, resulting in gaps in the lattice pattern, which
peaked three days post exercise and decreased with time (9).
Damage to the membrane or sarcoplasmic reticulum (SR) would allow calcium
(Ca"+) to move down its concentration gradient from the extracellular space into the
cytosol, potentially increasing the level of intracellular Ca2+ and resulting in a loss of
calcium homeostasis. Duan et ah found that rat skeletal muscle had elevated
mitochondrial Ca2+ levels following injury from downhill walking (10). High levels of
Ca2+ have the potential to activate various molecular pathways in skeletal muscle, such as
the calpain proteolytic pathways and the phospholipase A2 pathway. Calpains are
thought to play a role in muscle damage by being responsible for the initial breakdown of
myofibrils and cytoskeletal proteins (eg. desmin, a-actinin) (11). Activation of
phospholipase hi pathway may contribute to further post-exercise muscle damage of the
sarcolemma, thus increasing the loss of intracellular molecules (12). To further support
the role that elevated Ca~+ plays in the injury process, it has been observed that when
muscle fibres are treated with calcium chelators (EDTA and EGTA) there is a reduced
accumulation of Ca2+ in the mitochondria that is accompanied by an attenuation in
muscle fibre injury (10). The inability of skeletal muscle to buffer the damage related
increase in intracellular Ca2+ may lead to further damage in the muscle.
Structural alterations within the muscle are accompanied by the leakage of
proteins such as myoglobin and creatine kinase (CK) out of the cell and into circulation.
CK is a metabolic enzyme located intracellularly in muscles. Due to its location and
solubility it is able to cross the muscle sarcolemma membrane if the membrane is
damaged or disrupted. Therefore, measurements of CK release are an indirect indicator

3

of muscle membrane damage (13). Another common indicator of muscle damage is (3glucuronidase. Measurements of the activity of the lysosomal acid hydrolase (3glucuronidase have previously been shown to provide a quantitative indicator of exercise
induced muscle damage (14).
Performance of an exercise that causes muscle damage results in an adaptation in
the muscle. One bout of high force eccentric exercise is enough to elicit an adaptation
response in humans, such that the muscle is more resistant to damage and repairs at a
faster rate with subsequent bouts of exercise (15). The repeated bout effect has been
demonstrated not only in human but also in animal models, using various types of
activities employing different muscle groups (16). Several theories have been proposed
to explain the repeated bout effect, such as neural, connective tissue, or cellular
adaptations (16), but the specific mechanism has yet to be identified.

1.2 Skeletal Muscle Inflammation
Damage to muscle results in an inflammation response at the site of injury.
During inflammation, leukocytes, primarily neutrophils and monocytes/macrophages,
perform a wide range of functions preparing for repair and regeneration of the damaged
muscle.
Neutrophils rapidly invade muscle when damage occurs, and are present at
elevated levels when the injured fibres are being repaired. Neutrophils invade
immediately following exercise and remain elevated for as long as 5 days post-exercise
in humans (17). The time course varies with species but in general invasion of the
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damaged tissue by neutrophils can persist for days to weeks. Neutrophils have been
observed to peak 24 hrs following eccentric exercise in rats (18).
Neutrophils, along with monocytes and macrophages, play a critical role in
inflammation through removal of necrotic tissue cellular debris (19). Neutrophils release
cytokines that can attract and activate additional inflammatory cells (19). Neutrophils
assist in the degradation of damaged tissue or foreign matter primarily through their
phagocytic ability (20). Additionally, muscle proteins in the damaged areas may be
degraded by proteolytic systems introduced by infiltrating phagocytic cells, or by
proteases intrinsic to the muscle (21).
Neutrophils roll along the vessel wall searching the endothelium for signs of
inflammation and chemoattractants that can activate and initiate their adhesion to the
endothelium (22). At rest, more than half of the circulating neutrophils are located along
the endothelial walls of blood vessels (22). In response to exercise, the increase in
epinephrine, blood flow, and cell signaling molecules moves neutrophils away from the
vessel walls and mobilize them into circulation, where they are redistributed to their
required places in the body (23). In response to injury, the muscle cell communicates
with the endothelium wall of the adjacent blood vessel, signaling the movement of
neutrophils from circulation into the tissue. This communication is performed by a
variety of cytokines.
Cytokines are a diverse class of compounds that are extensively used for cellular
communication. All nucleated cells in the body produce cytokines and express cytokine
receptors on their surface membrane. Cytokines bind to a specific cell surface receptor
triggering a cascade of intracellular signals that are capable of altering cellular functions.
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Skeletal muscles produce cytokines such as, interleukin (IL) 1, 6 and 8, and tumour
necrosis factor (TNF) (24), in an effort to regulate function and maintain homeostasis. In
response to injury there is an increased expression of IL-1 and TNF-oc. These
proinflammatory cytokines are responsible for upregulating the expression of endothelial
leukocyte adhesion molecules and they play a role in initiating the breakdown of
damaged muscle tissue (25). Activating the endothelium can cause the release of
additional IL-1 and other proinflammatory cytokines, which recruit neutrophils to the site
of injury (26).
Additionally, oxygen radical formation by neutrophil bursts are important in
clearing away the damaged muscle tissue. The 50 to 100 fold increase in oxygen
consumption by neutrophils results in an increased production of cytotoxic oxygen
species, and possibly reactive nitrogen species (27). Nitric oxide (NO) was found to have
a protective effect on muscle cells from neutrophil mediated cytolysis in vitro (28).
Conversely, superoxide or superoxide derivatives have a cystolic function in neutrophil
mediated lysis of muscle cells in vitro (28).
There may be secondary or collateral damage that occurs with neutrophil invasion
of the muscle. When the generation of reactive radicals exceeds the ability of the tissue
antioxidants to detoxify them, then the oxidative stress present can lead to further muscle
damage (29). Release of high concentrations of cystolic and cytotoxic substances can
damage healthy tissue (30). A fine balance has to be maintained since both
overproduction and underproduction of superoxide by neutrophils can result in negative
consequences.
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Similar to neutrophils, macrophages are also capable of releasing reactive radicals
and cytotoxic enzymes to aid in tissue degeneration. Macrophages are formed from
undifferentiated monocytes circulating in the blood. In response to muscle damage
macrophages invade the muscle and will concentrate near damaged fibres, and may even
infiltrate the fibres (31).
Two main subpopulations of macrophages have been identified, ED1 + and ED2+.
ED1 + macrophages infiltrate muscle approximately 12-24 hours after exercise damage
(32). It is thought that macrophages, especially ED1 + macrophages, are responsible for
the phagocytosis of injured tissue and secretion of inflammation regulatory cytokines.
However ED2+ macrophages are thought to contribute to satellite cell activation and
proliferation in vivo (33). ED2+ macrophages infiltrate muscle during later regeneration
phase and induce satellite cell activation (34).
Activation of EDI + macrophages further contributes to inflammation by
producing and releasing a variety of substances, including proinflammatory cytokines
such as prostaglandins and IL-1 (3 (35). Not only is the macrophage response enhanced in
the tissue by cell signaling, but additional neutrophils are also recruited (35). Unlike
neutrophils, macrophages, in particular ED2+, release growth factors necessary for
muscle repair and regeneration. Most notable are the cell growth regulatory cytokines,
such as insulin-like growth factor (IGF-1), fibroblast growth factor (FGF), and
transforming growth factor-fjl (TGF-fil). These cytokines activate and recruit
fibroblasts (36). Fibroblasts provide the structural framework in muscles and play a
critical role in the repair process. Additionally, fibroblasts continue to secrete their own
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proinflammatory cytokines during the repair process, further contributing to the feedback
loop.

1.3 Skeletal Muscle Repair
Skeletal muscle has the capacity to adapt to the physiological stress placed on it
by growth, training and injury. As the removal of damaged tissue occurs, muscle fibre
regeneration occurs by activation of satellite cells. Macrophages are not only critical for
the removal of damaged and necrotic cellular debris, but they also attract myogenic
satellite cells to the site of injury and release cytokines that regulate the myogenic
satellite cell pool (37).
In undisturbed conditions, myogenic satellite cells remain in a non-proliferative,
quiescent state. Myogenic satellite cells are undifferentiated stem cells. Quiescent
myogenic satellite cells reside between the sarcolemma and the basal lamina. These cells
contain little cytoplasm and few organelles (38). In response to muscle injury, satellite
cells become activated and enter the cell cycle to provide the precursors required for new
muscle formation during growth and repair (39). The ability of satellite cells to enhance
muscle mass and repair muscle following injury makes them a vital component in
skeletal muscle.
In response to cellular and extracellular signals associated with muscle damage
satellite cells exit their quiescent state and migrate to the site of injury to repair or replace
damaged muscle fibres. The signaling cascade for satellite cell activation is
accomplished through the activating agents, nitric oxide (NO) released from the fibres or
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the release of HGF from the extracellular matrix (40). Activated satellite cells have
hypertrophied organelles and an expanded cytoplasm (38).
Following activation, satellite cells and myogenic precursor cells begin to
proliferate (41). Committed myoblasts continue to proliferate and express muscle
regulatory genes until the balance of protein expression drives the cells towards
differentiation (42). Fibroblast growth factor stimulates an increase in the proliferation of
satellite cells that have already been activated, however, it represses their ability to
differentiate (43). Furthermore, insulin-like growth factor can activate proliferation and
differentiation of satellite cells (43). Other factors that stimulate proliferation during
muscle repair include HGF, LIF, GH, IL-6, insulin, leptin and testosterone (44).
The third stage in skeletal muscle regeneration is differentiation. It is the process
whereby proliferating myoblasts formed from activated satellite cells, and other
myogenic precursors, leave the cell cycle and fuse with existing myofibres to repair
damaged segments or fuse together to form new myofibres during regeneration of
damaged skeletal muscle (45). Differentiation is initiated in response to cellular and
extracellular signals associated with muscle damage. Some factors that influence
differentiation of satellite cells have previously been listed, but also include LIF, GH,
insulin, IL-15, leptin and testosterone (44).
Following muscle regeneration the satellite cells return to a quiescent state.
Myogenic satellite cells are self-renewing; the residual pool of satellite cells is reestablished after each bout of injury. This beneficial process ensures that the pool of
satellite cells is not depleted and is made available for further rounds of regeneration.
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The distribution of satellite cells has been found to be distinctly different in the
relative number of satellite cells within oxidative and glycolytic muscles in animals. The
more oxidative fibres in muscle generally have a larger population of satellite cells (46).
Aged skeletal muscles are more prone than young ones to be susceptible to
exercise-induced muscle damage and their regenerative capacity is also impaired (47;
48). In the slow twitch muscle of the soleus and the fast twitch muscle of the extensor
digitorum longus muscles of rats there is a decline in satellite cell content with age (49).
In rats, the proliferation potential of satellite cells also decreases with age (47). Human
studies have also observed the same results. In the study by Kadi et al. (50), they
demonstrated that the satellite cell proportion is reduced in older adults compared to
younger women and men, implying that there is a reduction in the satellite cell pool as
age increases.

1.4 Influence of Estrogen
Estrogen hormones play a vital role in developing and maintaining normal sexual
and reproductive functions in both humans and animals. They also influence a variety of
tissues, such as the uterus, prostate, bone, breast, brain, colon, and muscle (51). The term
estrogen refers to three structurally similar steroid hormones: estrone, estriol, and
estradiol 17(3 (E2). E2 is the primary estrogen found within the body.
The primary practical purpose of studying the effects of estrogen in response to
skeletal muscle damage would be in order to gain further insight into the process in postmenopausal women. Post-menopausal women have reduced estrogen levels, and
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therefore may be more susceptible to muscle damage and have a slower recovery time
than pre-menopausal women.
In response to exercise-induced muscle damage, estrogen has been shown to
reduce leukocyte derived inflammation (18). In particular, neutrophil infiltration into
damaged muscle has been found to be reduced in response to estrogen supplementation
(52). Recall that neutrophils increase inflammation post-exercise as they invade into the
damaged muscles and produce oxidizing agents that are important in the clearance of
damaged tissue debris (19-21; 53). It is postulated that a reduction in neutrophils is
associated with a reduction in muscle damage, since neutrophils may exacerbate postexercise damage by the generation of the oxidizing agents. It has been demonstrated that
exercised female ovariectomized rats that received estrogen administration display an
attenuation in muscle damage (CK activity), leukocyte activity, neutrophil infiltration and
calpain-like activities as compared to exercised, unsupplemented animals (52).
Additionally, Tiidus and Bombardier (18) compared sexually mature male and female
rats and found a significant decrease in neutrophil infiltration post-exercise in female rats.
When the male rats were supplemented with estrogen, neutrophil infiltration was
attenuated to levels found in females. A reduction in neutrophils may decrease the
severity and time course of inflammation, potentially enhancing the healing process.
Macrophages are also important in the removal of damaged muscle; additionally
they are associated with the activation of muscle satellite cells and the repair process
(39). St. Pierre-Schneider et al. (54) set forth to determine the time course of leukocyte
invasion into damaged skeletal muscle of male and female mice. They reported a delay
of macrophage migration to injured muscles of female mice compared to males by
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several days following damage (54). McClung et al. (55) also found that a delay in
macrophage invasion following injury was associated with differences in estrogen status.
Ovariectomized female rats displayed an elevation in macrophage (ED1+ and ED2+)
infiltration relative to intact female rats, seven days following injury (55). These studies
demonstrate that macrophages are vital for a timely recovery from muscle damage and
that estrogen plays a critical role in that process.
In terms of satellite cell response, it has been found that estrogen supplemented
rats had an increase in muscle satellite cell content as compared to the rats that did not
receive estrogen supplementation (56). Recent work by Enns & Tiidus (57) has found
that estrogen supplemented animals had increased numbers of total, activated and
proliferating satellite cells compared to estrogen naive animals following exercise
induced muscle damage.
The mechanism by which estrogen influences the inflammation and repair process
in damaged skeletal muscle is still uncertain. The proposed mechanisms for estrogen's
effect may be through a direct nonspecific interaction with phospholipids, or by
interactions with other membrane components, or even through an antioxidant effect.
Understanding the mechanism behind estrogen's effects may allow us to optimize and
manipulate this process.
It has been suggested that estrogen may have a membrane stabilizing effect.
Estrogen is a fat-soluble hormone, capable of incorporating into the lipid bilayer of the
cell and stabilizing the membrane (58). It is thought that this interaction could alter the
fluidity and function of the membrane. Estrogen may incorporate into cell membranes,
similar to how cholesterol integrates, and may act in a comparable nature to optimize
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membrane fluidity and polyunsaturated fatty acid arrangement (59). Therefore, estrogen
may have the capacity to limit membrane disruption in response to damage by stabilizing
the membranes.
Additionally, estrogen may exert its effects through its antioxidant capacity.
Antioxidants are molecules that have the ability to neutralize the unpaired electron from
free radical species. Compounds with free radicals can cause chain reactions that damage
cells. Antioxidants remove the free radical intermediates and terminate these potentially
hazardous reactions. Estrogen possesses a hydroxyl group on its "A" (phenolic) ring, in
the same position and configuration as found on the antioxidant vitamin E (60). Similar
to vitamin E, estrogens may donate the hydrogen atoms from their phenolic hydroxyl
group, halting the free radical peroxidation chain reactions (60). In this respect, exposure
of skeletal muscle to estrogen may reduce muscle damage.
An alternative mechanism for estrogen's effect may be by direct receptor
mediated mechanisms. Skeletal muscle is known to possess a small number of
membrane bound estrogen receptors. Two estrogen receptors (ERs), ERa and ERp\ have
been characterized and are expressed in mammalian skeletal muscle (61; 62). The
specific roles that estrogen and its receptors serve in the muscle damage and repair
processes remain elusive. The proliferative actions of estrogen seem to require EPoc;
whereas the differentiative and anti-proliferative effects of estrogen may be controlled by
ERP in ovaries (63). Therefore, the relative tissue distribution of the estrogen receptors
may be a determinant in their form of action. Lemoine et al. (62) found that ERa levels
in (untrained rats') skeletal muscle are distributed differently. Slow twitch muscle
(soleus) had the greatest amount of ERa levels compared with an intermediate muscle
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(gastrocnemius) and a fast twitch muscle (extensor digitorum longus) (62). These results
are in agreement with those found in rabbits (64). Furthermore, it has been demonstrated
that ERa and ER(3 levels can be upregulated with exercise (65; 66).
Estrogen influences a variety of physiological and metabolic events within
muscle. It has already been stated that estrogen contributes to the inflammatory and
repair processes following skeletal muscle damage. Similar to the mechanisms behind
estrogen's effects, the signaling processes also need further investigation. To date, it is
known that estrogen influences the induction of heat shock proteins (HSPs). Heat shock
proteins are highly conserved stress proteins that are induced in response to stressors,
such as exercise and muscle damage (67). Their primary function is to act as chaperones,
to mediate the proper folding of denatured proteins (68). Exercise induced muscle
damage results in an increase in intracellular denatured proteins, signaling the induction
of the HSP response. A relationship between the induction of the HSP response and a
reduction in damage has been demonstrated in cardiac muscle. The induction of HSPs
resulted in cardioprotection and delayed the onset of myocardial injury caused by
ischemia (69). Paroo et al. (70) found a gender specific HSP response in rats. They
found that males displayed a greater induction of HSP70 in skeletal muscle than females
post-exercise (70). Moreover, ovariectomized rats supplemented with estrogen
demonstrated a reduction in HSP70 levels compared to placebo treated ovariectomized
rats, suggesting an estrogen mediated response (70). In support of these findings, it has
been shown that male rats supplemented with estrogen resulted in a HSP response similar
to those of females following exercise (71).
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1.5 Influence of Progesterone
Progesterone receptors are distributed in numerous tissues. In rats they have been
found to exist in the reproductive glands, certain regions of the oral mucosa and
developing teeth, esophagus, larynx, skin, mammary gland, kidney, and skeletal muscle
(72).
There has been limited work on the mechanism of progesterone's effect, but what
is known is that there is a similar distribution of estrogen and progesterone receptors in
most of the same cell types and tissues which may suggest that estrogen is involved in
progesterone receptor induction (72). In the uterus, progesterone's effect is mediated by
its receptors and estrogen increases progesterone receptor levels (73).
The interaction effects of progesterone and estrogen are limited, but it has been
demonstrated that the combined supplementation influences skeletal muscle fatigue (74).
In the study by St. Pierre-Schneider et al. (74) it was found that the time to fatigue was
greatest in ovariectomized mice treated with progesterone alone, even more so than
ovariectomized mice treated with placebo or a combination of estrogen and progesterone.
Furthermore, it was found that the ovariectomized mice treated with progesterone alone
had the greatest percent of isometric torque remaining immediately after eccentric
contractions, as compared to the ovariectomized mice treated with placebo, estrogen, or a
combination of estrogen and progesterone (74).
A related study done by Xing et al. (75) used the rat model to demonstrate the
effects that hormones had on leukocyte content in response to endothelium vascular
injury. They demonstrated that estrogen attenuated leukocyte populations and migration
into injured tissue. The addition of progesterone and estrogen in combination negated the

15

protective effect observed by estrogen alone. Additionally, progesterone administration
alone had no independent effect of leukocyte infiltration following damage (75).
The mechanism behind progesterone's actions has yet to be determined.
Additionally, the interaction effects of progesterone and estrogen still need to be explored
in order to determine their physiological significance. The practical implications of
exploring this area may be for post-menopausal females that could be more prone to
muscle injury. These women have altered hormone levels when they enter menopause
and hormone intervention strategies involving estrogen and progesterone may be of
importance. Additionally, further knowledge of the mechanisms behind muscle
inflammation can be optimized (e.g., ER involvement and estrogen/progesterone
interaction) to develop pharmaceutical or other intervention strategies to aid the skeletal
muscle inflammatory process.
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Chapter Two
Influence of Estrogen Receptor Blockage on Indices of Skeletal Muscle
Inflammation

Statement of Problem
The purpose of this study was to investigate the role of estrogen receptors (ER) on
muscle leukocyte (neutrophil and macrophage) infiltration following eccentric exercise
through administration of the ER antagonist ICI182, 780 to ovariectomized female rats
with or without estrogen supplementation.

Subsidiary Problem
A secondary objective was to examine differences in leukocyte infiltration in skeletal
muscle of different fibre types.

Hypotheses
1. It is hypothesized that leukocyte infiltration will be attenuated with estrogen
supplementation.
2. ER blocker administration will negate the attenuation of leukocytes induced by
estrogen supplementation.
3. Based on previous studies it is thought that both fast and slow muscle types will
display similar trends in leukocyte infiltration.
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Introduction
Unaccustomed strenuous exercise, especially eccentric exercise can cause muscle
damage. Muscle damage can be manifested as a loss in muscle function or mechanical
disruptions in the muscle architecture. Damage to muscle results in an inflammation
response at the site of injury. During inflammation, leukocytes, primarily neutrophils
and monocytes/macrophages perform a wide range of functions preparing for repair and
regeneration of the damaged muscle.
Neutrophils rapidly invade muscle when damage occurs, and are present at
elevated levels when the injured fibres are being repaired. Neutrophils invade
immediately following exercise and remain elevated for as long as 5 days post-exercise
in humans (76). Neutrophils have been observed to peak 24 hrs following eccentric
exercise in rat (18). Neutrophils, along with monocytes and macrophages, play a critical
role in inflammation through removal of necrotic tissue cellular debris (19). In response
to muscle damage macrophages invade the muscle and will concentrate near damaged
fibres, and may even infiltrate the fibres (77). Two main subpopulations of macrophages
have been identified, ED1 + and ED2+. ED1 + macrophages infiltrate muscle
approximately 12-24 hr after exercise induced damage (19). It is thought that
macrophages, especially ED1 + macrophages, are responsible for the phagocytosis of
injured tissue and secretion of inflammation regulatory cytokines. In contrast, ED2+
macrophages are thought to contribute to satellite cell activation and proliferation in vivo
(33).
In response to exercise-induced muscle damage, estrogen has been shown to
reduce leukocyte derived inflammation (18). In particular, neutrophil infiltration into
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damaged muscle has been found to be reduced in response to estrogen supplementation
(52). It has been demonstrated that exercised female ovariectomized rats that received
estrogen administration display an attenuation in muscle damage (CK activity), leukocyte
activity, neutrophil infiltration and calpain-like activities as compared to exercised,
unsupplemented animals (52). Additionally, Tiidus and Bombardier (18) compared
sexually mature male and female rats and found a significant decrease in neutrophil
infiltration post-exercise in female rats. When the male rats were supplemented with
estrogen, neutrophil infiltration was attenuated to levels found in females. A reduction in
neutrophils may decrease the severity and time course of inflammation, potentially
enhancing the healing process. St. Pierre-Schneider et al. (54) set forth to determine the
time course of leukocyte invasion into damaged skeletal muscle of male and female mice.
They reported a delay in leukocyte migration to injured muscles of female mice
compared to males by several days following damage (54). McClung et al. (55) also
found that a delay in macrophage invasion following injury was associated with
differences in estrogen status. Ovariectomized female rats displayed an elevation in
macrophage (ED1+ and ED2+) infiltration relative to intact female rats, seven days
following injury (55).
The mechanism by which estrogen influences the inflammation and repair process
in damaged skeletal muscle is still uncertain. Estrogen may exert its effect via direct
receptor mediated mechanisms. Skeletal muscle is known to process a small number of
membrane bound estrogen receptors. Two estrogen receptors (ERs) ERoc and ER(3 have
been characterized and are expressed in mammalian skeletal muscle (61; 62). The
specific roles that estrogen and its receptors serve in the muscle damage process remain
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elusive. Slow twitch muscle (soleus) had the greatest amount of ERoc levels compared
with an intermediate muscle (gastrocnemius) and a fast twitch muscle (extensor
digitorum longus) (62). These results are in agreement with those found in rabbits (64).
Furthermore, it has been demonstrated that ERa and ER(3 levels can be upregulated with
exercise (65; 66).
In this study, we investigated the role of estrogen receptors (ER) on muscle
leukocyte (neutrophil and macrophage) infiltration following eccentric exercise through
administration of the pure ER antagonist ICI 182, 780 to ovariectomized female rats with
or without estrogen supplementation. The pure ER blocker binds with an extremely high
affinity and specificity to both ER a and (3 and possesses no estrogen agonistic properties
(78). Alternatively, estrogen may act via non-receptor mediated mechanisms, such as
direct interactions with other membrane components, or even through an antioxidant
effect.
We quantified the effects of estrogen supplementation and ICI 182, 780
administration on neutrophil and macrophage infiltration in red and white fibre types of
rat skeletal muscle following downhill running. The neutrophil marker His48 and the
macrophage marker EDI were quantified 24 hr post-exercise. In addition to measuring
leukocyte infiltration, muscle damage was indirectly assessed by measuring (3glucuronidase activity.
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Methods
Animals
The study was approved by the Animal Care Committee at Wilfrid Laurier University
and all procedures were performed in accordance with the Canada Council on Animal
Care. A total of 72 ovariectomized female Sprague-Dawley rats (Charles River
Laboratories, LaSalle, QC) were used in this study. The ovaries were surgically removed
at 9 weeks of age, and all animals were 10 weeks old upon arrival in our laboratory.
Animals were housed two per cage in an environmentally controlled environment with a
standard 12:12 light/dark cycle and allowed access to food (Tekland 22/5 Rodent Diet,
Harland-Tekland, Madison, WI) and water ad libitum.

Experimental Design
Following one week of acclimation in the laboratory, animals were randomly subdivided
into either the estrogen supplementation group or into the group receiving a sham
procedure. Half of the estrogen supplemented animals received injections of the pure
estrogen receptor blocker, ICI 182, 780, while the remaining animals received vehicle
injections. Each of these groups were further subdivided into exercise (sacrificed 24 and
72 hr post-exercise) and a control (unexercised) group, as illustrated in Figure 1. Thus
nine groups of rats (n = 7-9 rats per group) were used in this study.
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Figure 1: Schematic outline of the experimental protocol. CON = control (unexercised)
condition; EX = exercised condition.
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One day prior to and 6 days following estrogen pellet implantation (or sham
procedure), animals were injected with either ICI 182, 780 (5 mg kg" s.c, dissolved in
DMSO and diluted in corn oil, Cookson Inc., Ellisville, MO, USA) or a placebo (corn
oil/DMSO) solution.
The estrogen pellet implantation and sham procedures were performed under
aseptic conditions. Rats were anaesthetized via inhaled isoflurane, and a small incision
was made in the skin folds of the neck. Blunt dissection was used to separate the skin
from the underlying fascia. For the estrogen-supplemented animals, the estrogen pellet
0.25 mg 17(3-estradiol, 21-day time release pellet (Innovative Research of America,
Sarasota, FL) was inserted under the skin approximately 1 cm from the site of incision
using forceps. For the sham procedure, blunt dissection and insertion of the forceps was
performed similar to estrogen pellet procedure, but without a pellet insertion. The
incision was sealed with Vetabond (3M St. Paul, MN). Animals were allowed to recover
for 8 days prior to beginning the exercise protocol. This recovery time also allowed the
pellet implanted groups to receive prolonged exposure to estrogen.
The animals being exercised were exposed to 5 minute familiarization sessions,
one and two days prior to performing the exercise protocol. The animals ran on a
motorized rodent treadmill with an electric shock grid (Columbus Instruments,
Columbus, OH). The exercised animals ran on the treadmill at a -13.5° grade at a speed
of 17 m/min. They ran for a total of 90 min using an intermittent protocol of 5 min
running interspersed with 2 min of rest, as described elsewhere (79). This protocol is
non-fatiguing and has been shown to elicit damage in the soleus and white vastus muscles
in rodents (14; 80).
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Tissue collection
All animals were sacrificed by an overdose of sodium pentobarbital (55 mg/kg i.p.). The
exercised animals were sacrificed at 24 and 72 hours post-exercise. The control animals
were euthanized at the same time as the exercised animals. Anesthesia was confirmed
with the loss of withdrawal reflex from a toe web pinch. During sacrifice, the lower
abdomen was opened and a blood sample (5 mL) was withdrawn from the descending
aorta. Blood was allowed to clot, and centrifuged for 10 minutes at 3000 g. The serum
was removed and stored at -20°C. The soleus and superficial (white) portion of the
vastus muscle and uterus were removed. These muscle regions contain predominately
Type I and Type lib fibres, respectively (81). Tissue samples were thoroughly rinsed in
physiological saline to remove excess blood, blotted dry and trimmed of visible
connective tissue and tendons and also weighted in the case of the uteri to determine wet
weight. The uteri were then dried in the oven to determine dry weight values. The fibres
of the muscle were properly aligned and the muscle samples were mounted and coated in
optimal cutting temperature (OCT) medium and quickly frozen in isopentane chilled to
the temperature of liquid nitrogen, in preparation for immunohistochemical analysis. All
tissue samples were immediately placed in liquid nitrogen, then stored at -20°C until
analysis.

Serum Estrogen Assay
Serum estrogen levels were analyzed (in duplicate) using a commercially available
radioimmunoassay (RIA) kit (Coat-a-Count TKE21, Inter Medico, Markham, ON).
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^•Glucuronidase Activity Assay
p-glucuronidase activity was measured in the muscle samples using the method of Barrett
(82) as described by Koskinen et al. (83). Samples were assayed (in triplicate) at 420 nm.
Samples were expressed as the amount of substrate (5 mM p-nitrophenyl-p-Dglucuronide, Sigma-Aldrich) hydrolyzed per amount of protein and incubation time. To
determine the total protein content in the samples the Lowry Protein Assay was
performed (84).

Lowry Protein Assay to Determine Total Protein Content
Total protein content in muscle homogenates was measured using the Lowry Protein
Assay (84). Each sample was assayed (in triplicate) at 650 nm. Measured protein values
were corrected against a "blank" (water sample) and compared against a bovine serum
albumin standard (Sigma-Aldrich, St. Louis, MO).

Immunohistochemistry to Determine Inflammatory Response
Neutrophil and macrophage cells in soleus and white vastus muscles were determined by
sectioning the muscles onto Vectabond coated glass slides (Vector Laboratories,
Burlington, ON). Transverse serial sections of soleus and white vastus muscles were cut
at 7 (J,m using a cryostat (Leica CM3050S, Germany) at -20°C. The slides were stored at
-20°C until staining. Sections were immunostained for the leukocyte markers: His48
(present primarily on neutrophils) (85) and EDI (present primarily on macrophages) (86).
To quantify the cells, slides were placed under a light microscope (Leica DMLS)
with the image projected onto a computer screen at a magnification of 400x (lOx ocular
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and 40x objective lens). Twenty random fields were selected and ten fibres from those
fields were analyzed. This procedure was performed on two different cross sections of
the same muscle, for a total of 400 fibres being analyzed from each sample. Cells on the
outer edges of the cross section and those present in the blood were excluded during
quantification. Figure 2 depicts representative positive cells that were used during the
quantification of leukocytes.

Statistical Analysis
All data are presented as means ± SEM. Differences between groups were measured
using a 2 (exercise) by 3 (conditions) factorial ANOVA at a level of significance of
P < 0.05. Where significance was obtained, post-hoc multiple comparison testing was
done using a Bonferroni test to determine where specific differences had occurred.
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Figure 2: Representative images showing sections (7 |im) of rat skeletal muscles
immunostained for (A) neutrophils (His48) and (B) macrophages (EDI) (400x
magnification).
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Results
Serum Estrogen Levels
Since exercise and time of sacrifice had no effect on serum estrogen levels, animals were
pooled into three groups according to their supplementation status: sham, estrogensupplemented and estrogen-supplemented plus blocker (ICI 182,780) groups. As
depicted in Table 1, estrogen administered rats had significantly higher (P < 0.05) serum
estrogen levels relative to sham (unsupplemented) rats. Furthermore, serum estrogen
levels of estrogen-supplemented plus blocker (IC 182, 780) animals were significantly
greater (P < 0.05) than both sham animals and those that received estrogen alone. There
was no significant difference (P > 0.05) between estrogen-supplemented animals and
those receiving both estrogen supplementation plus blocker (ICI 182,780).

Body Weights
All groups continued to gain weight throughout the experimental period. However, sham
(unsupplemented) animals were significantly heavier than estrogen only treated animals
and estrogen plus ER antagonist supplemented animals at the time of sacrifice (P < 0.05),
as depicted in Table 2. There was no significant weight difference between estrogen
supplemented and estrogen plus ER antagonist supplemented groups (P > 0.05) at
sacrifice. These data are in line with previous work demonstrating that estrogen
administration to estrogen naive animals results in reduced body weight gain and lower
body mass (52; 57) than sham (unsupplemented) animals. Age matched animals were
chosen for the present study because weight matching between the groups would have
involved using estrogen treated and estrogen plus ER antagonist supplemented animals of
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higher age than sham animals. Since the present study was interested in using adult
female rats, the experimental design avoids differences in age and age-related differences
in hormonal status as confounding factors.

Uterus Weights
Estrogen binding to uterine estrogen receptors stimulates uterine growth; whereas binding
of a receptor antagonist, such as ICI 182,780 to ERs will inhibit uterine growth (87). As
depicted in Table 2, estrogen supplementation resulted in significantly greater (P < 0.05)
uterus wet and dry weights compared to sham (unsupplemented) animals. Administration
of blocker also resulted in significantly higher wet weight and dry weight relative to the
sham animals (P < 0.05). Additionally, the blocker group had a 22% lower uterus wet
weight and a 38% lower uterus dry weight compared to estrogen administration alone
(P < 0.05). When the weights were normalized to overall body weights of the rats, these
same trends were observed.

^-Glucuronidase Activity
To determine whether the exercise protocol resulted in lower exercised induced muscle
damage in estrogen supplemented animals relative to estrogen naive animals,
measurements of the activity of the lysosomal acid hydrolase, ^-glucuronidase were
assessed. Indeed, estrogen supplemented animals displayed significantly less (P < 0.05)
(3-glucuronidase activity 72 hours post-exercise than ovariectomized females in the soleus
and white vastus muscles, as depicted in Table 3. In ovariectomized animals,
administration of estrogen plus ICI 182, 780 significantly attenuated (P < 0.05) |3-
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glucuronidase activity 72 hours post-exercise in soleus and white vastus muscles, relative
to sham (unsupplemented) animals; similar to the effects of estrogen only
supplementation.

Leukocytes Infiltration
Leukocyte infiltration was measured by immunostaining for the neutrophil marker,
His48, and the macrophage marker, EDI. A main effect with exercise was observed in
neutrophils and macrophages, with control (unexercised) animals demonstrating
significantly lower (P<0.05) leukocyte content compared to animals 24 hours after
exercise in both muscle types. Increased neutrophil infiltration was observed 24 hours
after exercise (Figures 3 and 4). A significant increase was observed in the soleus and
white vastus muscle post-exercise (P < 0.05). In addition, macrophage infiltration was
significantly increased (P < 0.05) post-exercise in both muscle types (Figures 5 and 6).
Post-exercise, leukocyte infiltration was significantly reduced (P < 0.05) in estrogen
supplemented animals compared to sham animals. Estrogen supplementation attenuated
neutrophil infiltration by 33% in the white vastus muscle. Administration of estrogen
reduced macrophage infiltration by 37 and 36% in the soleus and white vastus,
respectively. The estrogen receptor antagonist, ICI 182, 780 did not significantly alter
the attenuating affect of estrogen on neutrophil and macrophage infiltration in both
muscle types.
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Table 1: Animal body weights and serum estradiol levels for sham, estrogen and
estrogen + ICI 182, 780 treatment groups. Values are pooled means + SEM. a P < 0.05
compared to sham treated. P < 0.05 compared to estrogen-supplemented.
Body Weight (g)

Serum Estrodiol (pg ml"1)

Sham

294 ± 4

12.5 ± 1

Estrogen

260 ± 3 a

79.3 ± 15a

Estrogen +
ICI 182, 780

260 ± 3 a

Treatment

141.6 ±28.6 ab
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Table 2: Changes of uterus weights with estrogen status. Values are pooled means +
SEM. a P < 0.0;
0.05 compared to sham treated. b P < 0.05 compared to estrogen
supplemented.
Estrogen

Sham
Wet weight, g
Wet weight, g per 100 g body weight
Dry weight, g
Dry weight, g per 100 g body weight

0.098 ±
0.033 ±
0.027 ±
0.009 ±
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0.005
0.002
0.003
0.001

0.396+ 0.0213
0.154 ±0.009 a
0.098 ± 0.009a
0.038 ± 0.004a

Estrogen +
ICI 182,780
0.313 ±0.016 ab
0.120 ±0.006 ab
0.061 ±0.003 a b
0.024 ±0.001 a,b

Table 3: Changes in muscle (3-Glucuronidase activity with downhill running. Values are
means + SEM. a P < 0.05 compared to unexercised controls. b P < 0.05 compared to
sham treated.
Sham
Soleus

White Vastus

Control
Exercise + 24 h
Exercise + 72 h
Control
Exercise + 24 h
Exercise + 72 h

Estrogen

5.26 + 0.27
6.49 ± 0.40a
8.04 ± 0.88a
4.71+0.39
5.86 ± 0.45a
6.19±0.57 a
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Estrogen +
ICI 182,780
4.55 ±0.20 4.46 ± 0.29
4.77 ±0.33 4.94 ± 0.48
5.11 ±0.41 b 4.97 ± 0.38b
4.04 ±0.21 3.72 ± 0.40
3.90 ± 0.20b 3.62±0.28 b
3.83 ±0.12" 3.54±0.33 b
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Figure 3: Effects of estrogen supplementation and ICI 182,780 administration on
numbers of His48+ neutrophils in rat soleus (red) muscle 24 h following downhill
running. Values are means + SEM. a P < 0.05 compared to Control (unexercised).
b
P < 0.05 compared to Sham treated
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Figure 4: Effects of estrogen supplementation and ICI 182,780 administration on
numbers of His48+ neutrophils in rat white vastus muscle 24 h following downhill
running. Values are means + SEM. a P < 0.05 compared to Control (unexercised).
b
P < 0.05 compared to Sham treated
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Figure 5: Effects of estrogen supplementation and ICI 182,780 administration on
numbers of EDI + macrophages in rat soleus (red) muscle 24 h following downhill
running. Values are means + SEM. a P < 0.05 compared to Control (unexercised).
b
P < 0.05 compared to Sham treated.
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Figure 6: Effects of estrogen supplementation and ICI 182,780 administration on
numbers of EDI + macrophages in rat white vastus muscle 24 h following downhill
running. Values are means + SEM. a P < 0.05 compared to Control (unexercised).
b
P < 0.05 compared to Sham treated.
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Discussion
The primary goal of this study was to gain further insight into the mechanism by
which estrogen exerts its effects. It has been well established that estrogen reduces postexercise skeletal muscle damage. However, what is unknown is the mechanism behind
estrogen's effects. We took the approach of examining the influence of estrogen
receptors on estrogen effects on muscle leukocyte inflammation. We blocked the
estrogen receptors with ICI 182, 780 to see if this altered estrogen's action on these
parameters.
Previously, tamoxifen has been used as an estrogen receptor blocker, however the
results from these experiments should be interpreted with caution due to tamoxifen's dual
properties. Not only does tamoxifen have estrogen antagonistic properties but it also
possesses agonistic characteristics (88). The use of a pure estrogen receptor blocker,
such as ICI 182, 780 provides more precise answers. This pure ER blocker binds with an
extremely high affinity and specificity to both ER a and B and possesses no estrogen
agonistic properties (78). The relative binding affinity of ICI 182, 780 to ERs is 0.89,
whereas the affinity of estrogen for its receptors is 1.0 (78). To verify the ovariectomy
was performed correctly and to quantify the biological response to treatment with
estrogen and ICI 182, 780, the uteri were weighed. ICI 182, 780 effectively blocked ERs,
as depicted by the significantly lower uterus wet and dry weights relative to the estrogen
only supplemented group.
As would be expected, estrogen only supplemented animals and those receiving
estrogen plus the blocker had significantly higher serum estradiol levels compared to the
unsupplemented ovariectomized animals. These levels are considered to be on the upper
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end of the physiological range and consistent with 17p-estradiol replacement values
found in other laboratories and our own (52; 89). The range of circulating estradiol levels
is quite large and variable. Age and stage of estrus cycle contribute to this variability.
Reported estradiol levels range as high as 285 pg ml"1 (90) to values such as 15 pg mf1
(91).
A major finding of the present study was the estrogen specific inflammatory
response; with estrogen supplementation animals demonstrated an attenuation of
leukocyte infiltration in skeletal muscle post-exercise compared to sham ovariectomized
animals. Furthermore, this differential response also appears to be affecting the degree of
muscle damage, as depicted by the lower (3-glucuronidase activity in estrogen
supplemented rats compared to sham ovariectomized rats. Moreover, the results suggest
that the mechanism by which estrogen is influencing this response is through a nonestrogen receptor mediated process. Although the present study does not directly assess
the involvement of the estrogen receptor as the mechanism behind estrogen's effects, if a
casual relationship exists, the administration of the ER antagonist, ICI182, 780 should
block estrogen's effect. However, ICI 182, 780 did not alter the ability of estrogen to
protect against skeletal muscle damage. There was no significant difference in Pglucuronidase activity between the animals that received estrogen supplementation alone
and those that received estrogen plus the ER antagonist. Furthermore, treatment of the
ovariectomized estrogen supplemented rats with ICI 182, 780 did not alter the leukocyte
inflammatory response to exercise relative to those treated with estrogen alone, indicating
that the hormonal mechanism is not primarily receptor mediated.
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Alternatively, the results suggest a possible enhanced muscle sarcolemma stability
with estrogen supplementation as the mechanism by which estrogen may influence
leukocyte infiltration and damage. Duan et al. found that rat skeletal muscle had elevated
mitochondrial Ca2+ levels following injury from downhill walking (10). High levels of
Ca2+ have the potential to activate various molecular pathways in skeletal muscle, such as
the calpain proteolytic pathways and the phospholipase A2 pathway. Calpains are
thought to play a role in muscle damage by being responsible for the initial breakdown of
myofibrils and cytoskeletal proteins (eg. desmin, a-actinin) (11). Activation of
phospholipase A2 may contribute to the role of muscle damage by further damaging the
sarcolemma and thus increasing the loss of intracellular molecules. To further support the
role that elevated Ca"+ plays in the injury process, it has been observed that when muscle
fibres are treated with chelators (EDTA and EGTA) there is a reduced accumulation of
Ca"+ in the mitochondria, that is accompanied by an attenuation in muscle fibre injury
(10).
Another possible mechanism for estrogen's effects may be through the induction
of heat shock proteins. Exercise induced muscle damage results in an increase in
intracellular denatured proteins, signaling the induction of the HSP response to mediate
the proper folding of denatured proteins (68). A relationship between the induction of
the HSP response and a reduction in damage has been demonstrated in cardiac muscle.
The induction of HSPs resulted in cardioprotection and delayed the onset of myocardial
injury caused by ischemia (69). There is an intrinsic gender HSP response in rats, with
males displaying a greater induction of HSP70 in skeletal muscle than females postexercise (70). Additionally, it has been shown that male rats supplemented with estrogen
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resulted in a HSP response similar to those of females following exercise (71).
Therefore, it is speculated that estrogen may exert its effect through one of the nonestrogen receptor mediated mechanisms, such as HSP induction or estrogenic
stabilization of the sarcolemma.
In summary, estrogen administration affected post-exercise leukocyte
inflammation. Estrogen administration attenuated post-exercise neutrophil and
macrophage content compared to estrogen naive animals. Combined estrogen plus ER
antagonist administration did not significantly alter the attenuation observed by estrogen
only administration. Hence, estrogen receptors may not be the primary mechanism by
which estrogen affects leukocyte inflammation.
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Chapter Three
The Effects of Progesterone on Estrogen Influence on the Indices of Skeletal Muscle
Inflammation

Statement of Problem
The purpose of this study was to examine the specific and interaction effects of estrogen
and progesterone on skeletal muscle in response to exercise induced damage.

Subsidiary Problem
A secondary objective was to examine differences in leukocyte infiltration in skeletal
muscle of different fibre types.

Hypotheses
1. It is hypothesized that leukocyte infiltration will be attenuated with estrogen
supplementation.
2. It is believed that the addition of progesterone and estrogen in combination will
negate the attenuation of leukocyte infiltration by estrogen supplementation alone.
3. It is hypothesized that progesterone administration alone will have no independent
effect on leukocyte infiltration.
4. Based on previous studies it is thought that both fast and slow muscle types will
display similar trends in leukocyte infiltration.
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Introduction
Muscle damage resulting from eccentric exercise can elicit leukocyte infiltration
at the site of injury. Neutrophils invade immediately following exercise and assist in the
degradation of damaged debris with their phagocytic and oxidative abilities (19; 92).
Macrophages infiltrate muscle approximately 12-24 hours post-exercise (19). They are
responsible for the removal of injured muscle debris, secretion of inflammation
regulatory cytokines and satellite cell activation (19; 20; 33).
Estrogen can influence the degree of exercise-induced muscle injury. Previous
work from our laboratory has demonstrated attenuating effects of estrogen on postexercise leukocyte infiltration (52) and enhanced muscle satellite cell activation (57). It
has been demonstrated that female ovariectomized rats that received estrogen
administration demonstrated an attenuation in muscle damage (CK activity), leukocyte
activity, neutrophil infiltration and calpain-like activities as compared to unsupplemented
animals post-exercise (52).
There has been limited work on the mechanism of progesterone's effect, but what
is known is that there is a similar distribution of estrogen and progesterone receptors in
most of the same cell types and tissues which may suggest that estrogen is involved in the
progesterone receptor induction (72). In the uterus, progesterone is mediated by its
receptors and estrogen increases progesterone receptor levels (73). Progesterone
receptors are distributed in numerous tissues. In rats they have been found to exist in the
reproductive glands, certain regions of the oral mucosa and developing teeth, esophagus,
larynx, skin, mammary gland, kidney, and skeletal muscle (72).
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The interaction effects of progesterone and estrogen are limited, but it has been
demonstrated that the combined supplementation influences skeletal muscle fatigue (74).
In the study by St. Pierre Schneider et al (74), it was found that the time to fatigue was
greatest in ovariectomized mice treated with progesterone alone, even more so than
ovariectomized mice treated with placebo or a combination of estradiol and progesterone.
Furthermore, it was found that the ovariectomized mice treated with progesterone alone
had the greatest percent of isometric torque remaining immediately after eccentric
contractions, as compared to the ovariectomized mice treated with placebo, estradiol, or a
combination of estradiol and progesterone (74).
A related study by Xing et al. (75), used the rat model to demonstrate the effects
that hormones had on leukocyte content in response to endothelium vascular injury.
They demonstrated that estrogen attenuated leukocyte populations and migration into
injured tissue. The addition of progesterone and estrogen in combination negated the
protective effect observed by estrogen alone. Additionally, progesterone administration
alone had no independent effect of leukocyte infiltration following damage (75).
In this study, we examined the specific and interaction effects of estrogen and
progesterone on skeletal muscle in response to injury. We quantified the effects of
progesterone and estrogen supplementation on leukocyte (neutrophil and macrophage)
infiltration in red and white fibre types of rat skeletal muscle following downhill running.
The neutrophil marker His48 and the macrophage marker EDI were quantified 24 hr
post-exercise. In addition to measuring leukocyte infiltration, muscle damage was
indirectly assessed by measuring p-glucuronidase activity.

44

Methods
Animals
The study was approved by the Animal Care Committee at Wilfrid Laurier University
and all procedures were performed in accordance with the Canada Council on Animal
Care. A total of 63 ovariectomized Sprague-Dawley rats (Charles River Laboratories,
LaSalle, QC) were be used. One animal was removed from the study due to illness. The
animals had their ovaries removed at 9 weeks and be delivered at 10 weeks old. Animals
were housed two per cage in an environmentally controlled environment with a standard
12:12 light/dark cycle and allowed access to food (Tekland 22/5 Rodent Diet, HarlandTekland, Madison, WI) and water ad libitum.

Experimental Design
Following one week of acclimation in the laboratory, animals were being randomly
subdivided into four groups: estrogen supplemented group, progesterone supplemented
group, progesterone plus estrogen supplemented group or into the group receiving a sham
procedure. The groups were further subdivided into exercise or control (unexercised)
groups.
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Ovariectomized female rats
n=63

Estrogen
n=16

Sham
n=16

CON
n=8

EX
n=8

CON
n=8

EX
n=8

Progesterone
n=16

CON
n=8

EX
n=8

Estrogen +
Progesterone
n=15

CON
n=8

EX
n=7

Figure 7: Schematic outline of the experimental protocol. CON = control (unexercised)
condition; EX = exercised condition.
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Pellet implantation and sham procedures were performed under aseptic
conditions. Rats were anaesthetized via inhaled isoflurane, and a small incision was
made in the skin folds of the neck. Blunt dissection was used to separate the skin from the
underlying fascia. For supplemented animals, the estrogen pellet (0.25 mg 17(3-estradiol,
21-day time release pellet, Innovative Research of America, Sarasota, FL) and/or the
progesterone pellet (25 mg progesterone, 21-day time release pellet, Innovative Research
of America, Sarasota, FL) were inserted under the skin approximately 1-2 cm from the
site of incision using forceps. For the sham procedure, blunt dissection and insertion of
the forceps was performed similar to pellet procedure, but without a pellet insertion. The
incision was sealed with Vetabond (3M St. Paul, MN) and skin staples (APPOSE ULC,
USS DG, USA). Animals were allowed to recover for 7 days prior to beginning the
exercise protocol. This recovery time also allowed the pellet implanted groups to receive
prolonged exposure to hormones.
The animals being exercised were exposed to 5 minute familiarization sessions,
one and two days prior to performing the exercise protocol. The animals ran on a
motorized rodent treadmill with an electric shock grid (Columbus Instruments,
Columbus, OH). The exercised animals were run on a motorized rodent treadmill
downhill at a -13.5° grade at a speed of 17 m/min. They ran for a total of 90 min using
an intermittent protocol of 5 min running interspersed with 2 min of rest, as described
elsewhere (79). This protocol is non-fatiguing and has been shown to elicit damage in
the soleus and white vastus muscles in rodents (14; 80).
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Tissue collection
All animals were sacrificed by an overdose of sodium pentobarbital (55 mg/kg i.p.). The
exercised animals were sacrificed 24 hours post-exercise. The control animals were
euthanized at the same time as the exercised animals. Anesthesia was confirmed with the
loss of withdrawal reflex from a toe web pinch. During sacrifice, the lower abdomen was
opened and a blood sample (5 mL) was withdrawn from the descending aorta. Blood was
allowed to clot, and centrifuged for 10 minutes at 3000 g. The serum was removed and
stored at -20°C. The soleus and superficial (white) portion of the vastus muscle and
uterus were removed. These muscle regions contain predominately Type I and Type lib
fibres, respectively (81). Tissue samples were thoroughly rinsed in physiological saline
to remove excess blood, blotted dry and trimmed of visible connective tissue and
tendons. The fibres of the muscle were properly aligned and the muscle samples were
mounted and coated in optimal cutting temperature (OCT) medium and quickly frozen in
isopentane chilled to the temperature of liquid nitrogen, in preparation for
immunohistochemical analysis. All tissue samples were immediately placed in liquid
nitrogen, then stored at -20°C until analysis.

Serum Estrogen Assay
Serum estrogen levels were analyzed in duplicate using a commercially available
radioimmunoassay (RIA) kit (Coat-a-Count TKE21, Inter Medico, Markham, ON).
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Progesterone Level Assay
Serum progesterone levels were analyzed in duplicate using a commercially available
radioimmunoassay (RIA) kit (Coat-a-Count TKPG2, Inter Medico, Markham, ON).

^•Glucuronidase Activity Assay
(3-glucuronidase activity was measured in the muscle samples using the method of Barrett
(82) as described by Koskinen et al. (83). Samples were assayed in triplicate at 420 nm.
Samples were expressed as the amount of substrate (5 mM p-nitrophenyl-P-Dglucuronide, Sigma-Aldrich) hydrolyzed per amount of protein and incubation time. To
determine the total protein content in the samples the Lowry Protein Assay was
performed (84).

Lowry Protein Assay to Determine Total Protein Content
Total protein content in muscle homogenates was measured using the Lowry Protein
Assay (84). Each sample was assayed in triplicate at 650 nm. Measured protein values
were corrected against a "blank" (water sample) and compared against a bovine serum
albumin standard (Sigma-Aldrich, St. Louis, MO).

Immunohistochemistry to Determine Inflammatory Response
Neutrophil and macrophage cells in soleus and white vastus muscles were determined by
sectioning the muscles onto Vactabond coated glass slides (Vector Laboratories,
Burlington, ON). Transverse serial sections of soleus and white vastus muscles were cut
at 10 \im using a cryostat (Leica CM3050S, Germany) at -20°C. The slides were stored at
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-20°C until staining. Sections were immunostained for the leukocyte markers: His48
(present primarily on neutrophils) and EDI (present primarily on macrophages).
To quantify the cells, slides were placed under a light microscope (Leica DMLS)
with the image projected onto a computer screen at a magnification of 400x (lOx ocular
and 40x objective lens). Twenty random fields were selected and ten fibres from those
fields were analyzed. This procedure was performed on two different cross sections of
the same muscle, for a total of 400 fibres being analyzed from each sample. Cells on the
outer edges of the cross section and those present in blood were excluded during
quantification. Figure 8 depicts representative positive cells that were used during the
quantification of leukocytes.

Statistical Analysis
All data are presented as means ± SEM. Differences between groups were measured
using a 2 (exercise) by 3 (conditions) factorial ANOVA at a level of significance of P <
0.05. Where significance was obtained, post-hoc multiple comparison testing was done
using a Bonferroni test to determine where specific differences had occurred.
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Figure 8: Representative images showing sections (10 fxm) of rat skeletal muscles
immunostained for (A) neutrophils (His48) and (B) macrophages (EDI) (400x
magnification).
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Results
Serum Estrogen Levels
Since exercise had no effect on serum estrogen levels, animals were pooled into four
groups according to their supplementation status: sham, progesterone-supplemented,
estrogen-supplemented and progesterone plus estrogen-supplemented groups. As
depicted in Table 4, estrogen administered rats had significantly higher (P < 0.05) serum
estrogen levels relative to sham (unsupplemented) and progesterone treated rats.
Additionally, serum estrogen levels of progesterone plus estrogen-supplemented animals
were significantly greater (P < 0.05) than both sham animals and those that received only
progesterone treatment. There was no significant difference (P > 0.05) between estrogensupplemented animals and those receiving both progesterone plus estrogen
supplementation.

Serum progesterone levels
Since exercise had no effect on serum progesterone levels, animals were pooled into four
groups: sham, progesterone-supplemented, estrogen-supplemented and progesterone plus
estrogen-supplemented groups. As seen in Table 4, progesterone-supplemented animals
had greater serum progesterone concentrations than sham (unsupplemented) rats (P <
0.05). Additionally, progesterone plus estrogen-supplemented animals had significantly
greater serum progesterone levels relative to estrogen-supplemented and sham
(unsupplemented) rats (P > 0.05). There was no significant difference (P > 0.05) between
progesterone only supplemented animals and those receiving both progesterone plus
estrogen supplementation.
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Body Weights
All groups continued to gain weight throughout the experimental period. However, sham
(unsupplemented) animals were significantly heavier than estrogen only treated animals
and estrogen plus progesterone treated animals at the time of sacrifice (P < 0.05), as
depicted in Table 4. There was no significant weight difference between progesterone
supplemented animals and sham (unsupplemented) animals (P > 0.05) at sacrifice. These
data are in line with previous work demonstrating that estrogen administration to estrogen
naive animals results in reduced body weight gain and lower body mass than sham
(unsupplemented) animals (52; 57) and progesterone only supplemented animals (93).
Age matched animals were chosen for the present study because weight matching
between the groups would have involved using estrogen treated animals of higher age
than sham and progesterone only treated animals. Since the present study was interested
in using adult female rats, the experimental design avoids differences in age and agerelated differences in hormonal status as confounding factors.

^•Glucuronidase Activity
To determine whether the exercise protocol resulted in lower exercised induced muscle
damage in estrogen and/or progesterone supplemented animals relative to
unsupplemented animals, measurements of the activity of the lysosomal acid hydrolase,
P-glucuronidase were assessed. However, this assay detects muscle damage 72 hours
post-exercise, as demonstrated by previous studies performed by our laboratory (57); as
such, the present study did not display significantly differential responses in (3glucuronidase activity between groups 24 hours post-exercise (P > 0.05) .
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Leukocyte Infiltration
Leukocyte infiltration was measured by immunostaining for the neutrophil
marker, His48, and the macrophage marker, EDI. A main effect with exercise was
observed in neutrophils and macrophages, with control (unexercised) animals
demonstrating significantly lower (P < 0.05) leukocyte content compared to animals 24
hours after exercise in both muscle types. Also, a main effect with hormone
administration was observed in neutrophils and macrophages, for both the soleus and
white vastus muscles; the sham animals had significantly greater (P < 0.05) content than
the estrogen treated and estrogen plus progesterone treated animals. Also, the
progesterone only treated animals had significantly greater (P < 0.05) neutrophil and
macrophage content than the estrogen treated and estrogen plus progesterone treated
animals.
Significantly increased (P < 0.05) neutrophil infiltration was observed 24 hours
post-exercise in both the soleus and white vastus muscles relative to control (unexercised)
animals (Figures 9 and 10). Progesterone supplemented animals displayed significantly
decreased (P < 0.05) neutrophil infiltration following exercise compared to control
animals, in both muscle types. Estrogen supplementation significantly attenuated (P <
0.05) neutrophil infiltration compared to sham animals by 74 and 67% in the soleus and
white vastus, respectively. The combination of progesterone and estrogen
supplementation did not significantly alter the attenuating affect of estrogen in both
muscle types.
The number of macrophage cells detected in sections of the soleus and white
vastus muscles are depicted in Figure 11 and 12, respectively. There was a significant
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increase (P < 0.05) in muscle macrophage infiltration detected between control
(unexercised) and 24 hours post-exercise sham animals, for both muscle types. Postexercise, macrophage infiltration was significantly reduced (P < 0.05) in progesterone
supplemented animals compared to sham animals, in both muscle types. Additionally,
exercised animals that received estrogen supplementation significantly attenuated
(P < 0.05) macrophage infiltration in both the soleus and white vastus muscles. Estrogen
and progesterone combined supplementation did not significantly alter the attenuation
observed by estrogen alone.
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Table 4: Animal body weights, serum estradiol and progesterone levels for various
treatment groups. Values are pooled means + SEM. a P < 0.05 compared to sham
(unsupplemented). b P < 0.05 compared to progesterone-supplemented.c P < 0.05
compared to estrogen-supplemented.
Treatment

Body Weight (g)

Serum Estrodiol (pg ml"1) Serum Progesterone (ng ml"1)

Sham

290 + 5

18.9 + 2.2

1.07 + 0.2

Progesterone

293 ± 5

16.4±1.5

3.5±1.39 a

Estrogen

262 ± 4ab

153.0 ±35.0ab

1.41 ±0.35

Progesterone +
Estrogen

263 ± 5ab

101.2 ± 15.6ab

4.67 ± 0.73ac
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Table 5: Changes in Muscle (3-glucuronidase Activity With Downhill Running. Values
are means + SEM. a P < 0.05 compared to progesterone-supplemented animals. b P <
0.05 compared to estrogen-supplemented animals.

Soleus

Control
Exercise + 24 h
White Vastus Control
Exercise + 24 h

Sham

Progesterone

Estrogen

Progesterone +
Estrogen

5.32 ±0.42
5.70 + 0.54
2.92 ±0.31
3.23 ±0.45

6.42±0.44
5.09 ±1.12
2.66±0.25 b
4.20 ±0.47

4.21±0.63 a
4.02 + 0.64
4.39 ± 0.53
3.29 ±0.27

3.68±0.69 a
3.84 + 0.90
3.70 ±0.40
3.33 ±0.55
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Figure 9: Effects of estrogen and progesterone supplementation on numbers of His48+
neutrophils in rat soleus (red) muscle 24 h following downhill running. Values are means
+ SEM . a P < 0.05 compared to Control (unexercised), P < 0.05 compared to Sham
treated.). c P < 0.05 compared to Progesterone treated.
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Figure 10: Effects of estrogen and progesterone supplementation on numbers of His48+
neutrophils in rat white vastus muscle 24 h following downhill running. Values are means
a
+ SEM. P < 0.05 compared to Control (unexercised). P < 0.05 compared to Sham
treated.c P < 0.05 compared to Progesterone treated.
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Figure 11: Effects of estrogen and progesterone supplementation on numbers of ED1+
macrophages in rat soleus (red) muscle 24 h following downhill running. Values are
means + SEM. a P < 0.05 compared to Control (unexercised). b P < 0.05 compared to
Sham treated.c P < 0.05 compared to Progesterone treated.
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Figure 12: Effects of estrogen and progesterone supplementation on numbers of EDI+
macrophages in rat white vastus muscle 24 h following downhill running. Values are
means + SEM. a P < 0.05 compared to Control (unexercised). P < 0.05 compared to
Sham treated. c P < 0.05 compared to Progesterone treated.
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Discussion
We induced hormonal manipulation in the form of ovariectomized females to
examine the specific and interaction effects of estrogen and progesterone on skeletal
muscle in response to injury. It has been well established that estrogen reduces postexercise skeletal muscle damage. However, the influence of progesterone plus estrogen
in combination on skeletal muscle damage has not been extensively studied.
The major new findings of this study were that a) following exercise the
percentage of leukocyte infiltration decreased significantly with estrogen
supplementation in both muscle types, 67-69% and 63-74% in neutrophils and
macrophages, respectfully; b) the combination of estrogen and progesterone
supplementation did not significantly alter the attenuation observed by estrogen alone;
c) leukocyte infiltration post-exercise in the soleus (red) and white vastus muscles were
decreased in ovariectomized rats treated with progesterone alone relative to
unsupplemented ovariectomized rats.
As expected, the estrogen only supplemented animals and those receiving
estrogen plus progesterone had significantly higher serum estradiol levels compared to
the unsupplemented ovariectomized and progesterone only supplemented animals. These
levels are considered to be on the upper end of the physiological range and consistent
with 17(3-estradiol replacement values found in other laboratories and our own (52; 89).
Reported estrogen levels range as high as 285 pg ml"' (90) to values such as 15 pg ml"1
(91). Progesterone levels were considered to be at low physiological levels. The range
of circulating estrogen and progesterone levels are quite large and variable. Age and
stage of estrus cycle contribute to this variability. The rats in this study were exposed to
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constant levels of estrogen and/or progesterone. Under physiological conditions
concentrations are continuously fluctuating over a 3-4 day cycle. Therefore, a limitation
of this study is that the findings might not represent leukocyte infiltration in response to
damage that occurs when normal fluctuations occur in progesterone and estrogen levels.
This study demonstrated that skeletal muscle in female rats benefited from
progesterone treatment alone and in combination with estrogen following injury. The
protective effect of progesterone was depicted by its attenuation of leukocyte
inflammation. A novel finding was seen with the concurrent administration of estrogen
plus progesterone; progesterone and estrogen combined supplementation did not
significantly alter the attenuation observed by estrogen treatment alone in skeletal
muscle. Conversely, some studies have found that the addition of progesterone may
counteract the beneficial actions of estrogen. For example, in rat arteries following
vascular injury Xing et al. (75) observed that the addition of progesterone and estrogen in
combination negated the protective inflammatory effect observed by estrogen alone. The
estrogen dosage used in this study resulted in estrogen levels consistent with our study
(75). The progesterone dosage used was approximately 3 mg day"1, greater than our
dosage of 1.2 mg day"1.
In support of our findings, it has been shown that in the brain there is an
upregulation of progesterone receptors with the combined treatment of progesterone and
estrogen (94). Furthermore, Balaraman et al. (95) demonstrated that female rats with
progesterone administration displayed a cardioprotective effect following myocardial
ischemia/reperfusion (I/R) injury compared to males and ovariectomized females
receiving progesterone supplementation. Progesterone treated ischemic females showed
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significantly reduced muscle damage (serum CK levels), inflammation (neutrophil
infiltration), lipid peroxidation levels (superoxide dismutase and glutathione levels), and
apoptotic markers (DNA fragmentation) compared to vehicle treated I/R females (95).
The progesterone dosage of approximately 0.6 mg i.p. following I/R injury, along with
the endogenous circulating estrogen, was sufficient to elicit a response in the female rats.
Moreover, these findings suggest that there is an interaction effect with progesterone and
estrogen in female rats.
In conclusion, the present study not only demonstrates that progesterone
independently influences skeletal muscle leukocyte infiltration due to injury, but in
combination with estrogen, progesterone does not impede the attenuating influence of
estrogen on post-damage leukocyte infiltration.
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Chapter Four
Discussion & Conclusion
It is well known that estrogen influences muscle damage and repair processes.
The movement of leukocytes (neutrophils and macrophages) into skeletal muscle is a
critical response following injury. Our laboratory was the first to demonstrate that
estrogen replacement in ovariectomized female rats and male-supplemented rats resulted
in diminished leukocyte infiltration and inflammatory response in skeletal muscle (18).
We have also demonstrated that muscle damage in response to exercise is attenuated with
estrogen supplementation compared to sham (unsupplemented) animals (57). We have
begun to examine the mechanisms behind estrogen's influence on skeletal muscle
inflammation. Our laboratory's results demonstrated that estrogen administration to
ovariectomized female rats induces elevations in cardiac neutrophils while suppressing
calpain activity (96). Additionally, we have been examining the relationship between
estrogen and the muscle repair process. Recently our laboratory has found greater
numbers of total, activated and proliferating satellite cells post-exercise in estrogen
supplemented animals compared to the non-estrogen supplemented group. The results
demonstrate that estrogen may influence post-damage repair of skeletal muscle through
activation of satellite cells (57).
The mechanism by which estrogen influences inflammation in damaged skeletal
muscle needs to be examined further. Understanding the mechanism behind estrogen's
effects may allow us to optimize and manipulate this process. In the first study, we
investigated the role of estrogen receptors on muscle leukocyte infiltration following
eccentric exercise in ovariectomized female rats with or without estrogen
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supplementation. We blocked the estrogen receptors with ICI 182, 780 to see if this
altered estrogen's action on these parameters.
The study found an estrogen specific inflammatory response; with estrogen
supplemented animals demonstrating an attenuation of leukocyte infiltration in skeletal
muscle post-exercise compared to sham ovariectomized animals. Furthermore, treatment
of the ovariectomized estrogen supplemented rats with the ER antagonist, ICI 182, 780
did not alter the leukocyte inflammatory response to exercise relative to those treated with
estrogen alone, indicating that the hormonal mechanism is not primarily receptor
mediated.
Further work needs to be conducted in order to understand the mechanisms
behind estrogen's effects during inflammation. Our study was successful in ruling out the
estrogen receptors as the primary means by which estrogen exerts its effects. Perhaps
estrogen is acting via non-receptor mediated mechanisms, such as direct interactions with
other membrane components, induction of HSPs, or even through an antioxidant effect.
It has been suggested that estrogen may have a membrane stabilizing effect.
Estrogen is a fat-soluble hormone, capable of incorporating into the lipid bilayer of the
cell and stabilizing the membrane (58). It is thought that this interaction could alter the
fluidity and function of the membrane. Or perhaps, estrogen may possess antioxidant
properties, donating the hydrogen atoms from their phenolic hydroxyl group, halting the
free radical peroxidation chain reactions (60). In this respect, exposure of skeletal muscle
to estrogen may reduce muscle damage. Another possible mechanism for estrogen's
effects may be through the induction of heat shock proteins. Exercise induced muscle
damage results in an increase in intracellular denatured proteins, signaling the induction
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of the HSP response to mediate the proper folding of denatured proteins (68). A
relationship has been demonstrated between the induction of the HSP response and a
decrease in injury in cardiac muscle (69). Therefore, it is speculated that estrogen may
exert its effect through one of the non-estrogen receptor mediated mechanisms, such as
HSP induction, antioxidant effect or a membrane stabilization effect.
The vast majority of mammalian hormone based studies that examine
inflammation in response to muscle injury, only examine the influence of estrogen.
However, by only examining estrogen and not progesterone we are not gaining an
accurate understanding of the effects of female sex hormones. Therefore, we used a more
physiologically valid model in our second study to verify the effects of both estrogen and
progesterone alone in combination on leukocyte inflammation post-exercise. Our main
objective was to examine the effects that progesterone had on estrogen's ability to reduce
exercised induced muscle damage.
The study demonstrated that female rats benefited from progesterone and estrogen
treatment alone, as depicted by an attenuation in inflammation following injury. A novel
finding was seen with the concurrent administration of estrogen plus progesterone;
progesterone and estrogen combined supplementation did not alter the attenuation
observed by estrogen treatment alone in skeletal muscle. Therefore, progesterone and
estrogen in combination do not influence the leukocyte inflammatory response in an
additive or negating manner relative to estrogen supplementation alone following
exercise. Moreover, these results support earlier estrogen only studies. We now know
that the addition of progesterone, to make the study more physiologically relevant, would
not change these results.
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There has been limited work on the mechanism of progesterone's effect, but what
is known is that there is a similar distribution of estrogen and progesterone receptors in
most of the same cell types and tissues which may suggest that estrogen is involved in
progesterone receptor induction (72). In the uterus, progesterone's effect is mediated by
its receptors and estrogen increases progesterone receptor levels (73).
The practical implications of exploring this area may be for post-menopausal
females that could be more prone to muscle injury. These women have altered hormone
levels when they enter menopause and hormone intervention strategies involving
estrogen and progesterone may be of importance.
A limited number of estrogen replacement (in the form of hormonal replacement
therapy) studies have been conducted on postmenopausal women to assess their effects
on skeletal muscle damage. Even the examination of pre-menopausal and postmenopausal women's effects to skeletal muscle damage is scarce. Of the studies
conducted, it has been found that estrogen replacement did not offer a protective effect to
skeletal muscle from exercised induced damage (97; 98); since no significant differences
in serum creatine kinase levels were found among the groups. The results from human
based studies are not consistent with those of animal based studies. Perhaps this
discrepancy is due to the variability that exists in humans or the small samples sizes for
human based studies.
Additionally, further knowledge of the mechanisms behind muscle inflammation
can be optimized (eg. ER involvement and estrogen/progesterone interaction) to develop
pharmaceutical or other intervention strategies to aid the skeletal muscle inflammation
process.
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Appendix A
p-Glucuronidase Enzyme Assay
REACTION
p-nitrophenyl-beta-D-glucuronide +H2O — • alcohol + D-glucuronide + p-nitrophenyl

PROCEDURE
1. Homogenize tissue (10-20 mg; optimal 15 mg) in glass pestle using a 33.33:1
(3%) dilution using distilled water.
-use 16.66667 times the mass of tissue, do this 2 times
2. Add 50 jil of homogenate and water to appropriately labeled test tube
3. Add 450 |il of Acetate buffer to tubes using repeater pipette
4. Pre-incubate tubes in 37°C bath for 5 minutes
5. Add 250 (J,l of substrate using repeater pipette
6. Incubate for 16-18 hours tubes in 37°C bath
7. Add 1.5 ml of cold glycine buffer using repeater pipette
8. Cool in ice water for 10 minutes
9. Centrifuge at 3500 rpm for 10 minutes (temp 4°C)
10. Read on spectrophotometer at 420 nm.

REAGENT PREPARATION
1.Sodium acetate (anhydrous) (C2H302Na) (0.1N) (mw 82.03)
0.82 g in 100 ml of H 2 0
pH 4.2
2.Glycine Buffer (0.1M)
pH 10.8
A) 0.375g glycine (C2H5N02, mw 75.07) + 0.2922g NaCl (mw 58.44) in 50 ml H 2 0
B) 0.4 g of NaOH (mw 40) in 100 ml of H 2 0
Mix 52.2 ml of A and 47.8 ml of B and pH to 10.8
3) Substrate: p-nitrophenyl-beta-D-glucuronide (5mM) (sigma N-1627) (mw 315.2)
7.88 mg in 5 ml H 2 0

STANDARD PREPARATION
Standard: p-nitrophenol (10 mM liquid p-NP solution was purchased from Sigma)
Serial Dilution, mM
0.125
0.0625
0.03125
0.015625
0 (distilled water)

To make:
Take 563 |ll of 10 mM p-NP stock and add 437 (ll dH 2 0
Take 500 |il of 0.125 mM solution and add 500 jil dH 2 0
Take 500 jil of 0.0625 mM solution and add 500 jo.1 dH 2 0
Take 500 \il of 0.03125 mM solution and add 500 (xl dH 2 0
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Appendix B
HIS48 Immunohistochemistry
Used frozen sections of rat muscle cut 10 microns thick.
1.
2.
3.
4.
5.
6.
7.
8.

Let slides air dry for 5 min or until warmed up to room temperature.
Fix sections with 100% cold acetone for 10 min.
Let slides air dry for 5-10 min.
Permeablize cells in 0.5% Triton X-100 solution (in PBS) for 5 min.
Wash in PBS for 3 x 5 min.
Apply 0.6% H2O2 (in absolute methanol) for 10 min.
Wash in PBS for 3 x 5 min.
Block with 5% normal goat serum in PBS (containing 5% nonfat milk powder) for 30
min. Tap off excess.
9. Incubate in primary antibody: HIS48 (1/50 diluted in blocking solution) (BD
Biosciences, Mississauga, ON) for 3 h.
10. Wash in PBS for 3 x 5 min.
11. Apply bottle 3: GAM-Biotin (from Dako LSAB-2 kit) for 10 min.
12. Wash in PBS for 3 x 5 min.
13. Apply Bottle 4: Streptavidin-HRP (from Dako LSAB-2 kit) for 10 min.
14. Wash in PBS for 3 x 5 min.
15. Apply Vector NovaRed stain for 3 min (or until desired intensity is achieved).
16. Rinse in dt^O liberally from wash bottle, then wash in bath for 2 x 5 min.
17. Counterstain using Vector Hematoxylin QS (add hematoxylin for 10-15 s and rinse
off with running 37°C tap water for 30 s).
18. Place a drop of permanent mounting medium on cover slip and place slide upside
down onto cover slip so that mounting medium covers section completely.
19. Invert slide and apply gentle pressure on cover slip to remove any air bubbles.

Notes:
*

All kit reagents should be equilibrated to room temperature prior to procedures and
all incubations are done at room temperature
* Place all buffer baths on rocker for gentle agitation
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REAGENTS:
PBS, 0.015 M working solution (pH 7.6):
lxPBS
3.495 g
0.27 g
9.0 g

Na 2 HP0 4 * 7H20 (FW 268.1)
NaH 2 P0 4 * H26 (FW 138.0)
NaCl (FW 58.44)

lOx PBS
34.95 g
2.7 g
90 g

For lx PBS solution: Measure reagents, add approx. 950 ml dH 2 0, pH to 7.6, and bring
up to 1 L with dH 2 0. Store at room temperature.
For lOx PBS solution:
Measure reagents, add approx. 950 ml dH 2 0, pH to 7.6, and bring up to 1 L with dH 2 0.
Store at room temperature. Each day: take out 100 ml of 1 Ox stock PBS solution and add
900 ml dH 2 0.

0.5% Triton X-100 solution:
Add 5 ml of Triton X-100 to 995 ml of lx PBS. Store at room temperature.

0.6% HiOo solution (in MeOH):
Add 10 ml of 30% stock H 2 0 2 to 490 ml absolute methanol. Store at 4°C.

Blocking solution (5% normal goat serum in 5% nonfat milk powder/PBS):
For 10 ml:
Weigh out 0.5 g nonfat milk powder.
Add 9.5 ml lx PBS.
Add 500 |il normal goat serum.
Store at 4°C.
For 5 ml of a 1:50 dilution of His48 antibody:
Take 4.90 ml blocking solution and add 100 \il primary antibody (BD Biosciences,
Mississauga, ON).
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Appendix C
EDI Immunohistochemistry
Used frozen sections of rat muscle cut 10 microns thick.
1.
2.
3.
4.
5.
6.
7.
8.

Let slides air dry for 5 min or until warmed up to room temperature.
Fix sections with 100% cold acetone for 10 min.
Let slides air dry for 5-10 min.
Permeablize cells in 0.5% Triton X-100 solution (in PBS) for 5 min.
Wash in PBS for 3 x 5 min.
Apply 0.6% H2O2 (in absolute methanol) for 10 min.
Wash in PBS for 3 x 5 min.
Block with 5% normal goat serum in PBS (containing 5% nonfat milk powder) for 30
min. Tap off excess.
9. Incubate in primary antibody: EDI (1/100 diluted in blocking solution) (AbD Serotec,
Raleigh, NC) for 1 h.
10. Wash in PBS for 3 x 5 min.
11. Apply bottle 3: GAM-Biotin (from Dako LSAB-2 kit) for 10 min.
12. Wash in PBS for 3 x 5 min.
13. Apply Bottle 4: Streptavidin-HRP (from Dako LSAB-2 kit) for 10 min.
14. Wash in PBS for 3 x 5 min.
15. Apply Vector NovaRed stain for 4 min (or until desired intensity is achieved).
16. Rinse in dHiO liberally from wash bottle, then wash in bath for 2 x 5 min.
17. Counterstain using Vector Hematoxylin QS (add hematoxylin for 10-15 s and rinse
off with running 37°C tap water for 30 s).
18. Place a drop of permanent mounting medium on cover slip and place slide upside
down onto cover slip so that mounting medium covers section completely.
19. Invert slide and apply gentle pressure on cover slip to remove any air bubbles.

Notes:
*

All kit reagents should be equilibrated to room temperature prior to procedures and
all incubations are done at room temperature
* Place all buffer baths on rocker for gentle agitation
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Appendix D
Lowry Protein Assay
PROCEDURE:
1. Use 12*75 mm culture tubes and do samples, standards, and blanks in triplicate.
2. Add 50 (J.1 of standards to appropriately labelled tubes.
3. Add 50 ill of water to tubes labelled REAGENT BLANK.
4. Prepare a 20:1 dilution of homogenizing media (10 |il media + 190 (il water). Add 50
(LXl of dilute media to tubes labelled SAMPLE BLANK.
5. Prepare a 20:1 dilution of EACH tissue sample (10 |il sample + 190 |iil water). Add 50
|iil of dilute sample to tubes labelled SAMPLE.
6. Add 0.5 ml of alkaline copper reagent to all tubes.
7. Mix well and let stand for 10 minutes at 25°C (room temperature).
8. Add 2.0 ml of phenol reagent to each tube. Mix each tube individually
IMMEDIATELY after adding phenol reagent.
9. Incubate for 5 minutes at 55°C.
10. Cool in tap water for 1 minute.
11. Read on spectrophotometer at 650 nm.
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{PRIVATE IRE AGENTS:
1. ALKALINE COPPER REAGENT:
0.05 g CuS0 4 .5H 2 0
10.00 g Na 2 C0 3
0.10 g POTASSIUM SODIUM TARTRATE
2.00 g NaOH
TO 100 ml WATER ADD THE CuS0 4 AND DISSOLVE COMPLETELY. ADD
THE REMAINING REAGENTS IN ORDER. STORE AT 20°C FOR 2 WEEKS.

2. FOLIN-CIOCALTEU PHENOL REAGENT: (Sigma-Aldrich, St. Louis. MO)
TO 80 ml WATER ADD 5.0 ml of 2 N PHENOL REAGENT. MAKE FRESH
DAILY.

3. BOVINE SERUM ALBUMIN STANDARD, 1.0 mg/ml: (BSA.Sigma-Aldrich, St.
Louis, MO)
ADD 10 mg of BSA TO 10 ml WATER. MIX BY INVERSION. SERIAL
DILUTE TO OBTAIN SOLUTIONS AS FOLLOWS:
1.0 mg/ml
0.5 mg/ml
0.25 mg/ml
0.125 mg/ml
0.0 mg/ml

CALCULATION:
(A65o of sample - A6so of sample blank)

(A650 of standard - A650 of reagent blank)
Multiply by
Concentration of Standard (mg/ml) * 20 (dilution factor) = Protein concentration, mg/ml
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